Those shares will trade on the Nasdaq under the stock symbol ... myeloid leukemia (CML). This drug is a small molecule inhibitor of tyrosine kinases, enzymes that drive cancer growth.
Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.
Dealbreaker on MSN11d
Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the WorldAscentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...
Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's ...
PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...
As a result of the ADS Ratio Change, the ADS trading price is expected to increase proportionally. However, the Company can give no assurance that the ADS trading price after the ADS Ratio Change will ...
A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.
In Japan, the crane is considered a mythical animal that lives for 1,000 years; because of this, it became a symbol of good luck and ... to have caused her to develop leukemia as she got older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback